BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Allergy to pollen
,
Prostate
,
Alcohol
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
complement component C3b binding
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hemorrhagic shock
Contact dermatitis
Chlamydial infection
Sepsis due to coagulase negative Staphylococcus
Congenital leukocyte adherence deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Anthracyclines
MLN8054
Antigens, CD3
KW 2449
Glesatinib
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TBC1D23
RAB31
CYP2C19
AKT2
THRA
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Breast cancer cells co-cultured with fibroblasts expression profile
NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for complement component C3b binding
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers
Effects of Multiple Concussions in Retired NHL Players
Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis
First-in-Human (FIH) Clinical Study of NM8074 in Healthy Adult Volunteers
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ